AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
作者信息
Rinella Mary E, Neuschwander-Tetri Brent A, Siddiqui Mohammad Shadab, Abdelmalek Manal F, Caldwell Stephen, Barb Diana, Kleiner David E, Loomba Rohit
机构信息
University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.
Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
出版信息
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
Abstract
摘要
相似文献
1
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
2
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
N Engl J Med. 2017 Nov 23;377(21):2063-2072. doi: 10.1056/NEJMra1503519.
3
Is Liver Biopsy Necessary in Patients With Nonalcoholic Fatty Liver Disease?
Rev Med Chir Soc Med Nat Iasi. 2016 Jul-Sep;120(3):503-7.
4
Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.
Surg Pathol Clin. 2018 Jun;11(2):267-285. doi: 10.1016/j.path.2018.02.013.
5
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
Liver Transpl. 2018 Feb;24(2):166-170. doi: 10.1002/lt.25003.
6
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
World J Gastroenterol. 2019 Mar 21;25(11):1307-1326. doi: 10.3748/wjg.v25.i11.1307.
7
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.
World J Gastroenterol. 2024 May 28;30(20):2633-2637. doi: 10.3748/wjg.v30.i20.2633.
8
[Research progress of omics biomarkers for nonalcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):604-608. doi: 10.3760/cma.j.cn501113-20200708-00382.
9
[An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
Zhonghua Gan Zang Bing Za Zhi. 2017 Sep 20;25(9):687-694. doi: 10.3760/cma.j.issn.1007-3418.2017.09.008.
10
Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?
Metabolism. 2016 Aug;65(8):1087-95. doi: 10.1016/j.metabol.2016.01.013. Epub 2016 Feb 2.
引用本文的文献
1
Causal association between macrophage migration inhibitory factor and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study.
Medicine (Baltimore). 2025 Sep 5;104(36):e44106. doi: 10.1097/MD.0000000000044106.
2
Totum-448 Improves MASLD and Modulates Microbiota in Hamsters: Dose-Response Study and Effects of Supplementation Cessation.
Food Sci Nutr. 2025 Sep 2;13(9):e70904. doi: 10.1002/fsn3.70904. eCollection 2025 Sep.
3
Association between air pollution and risk of non-alcoholic fatty liver disease: an updated meta-analysis.
Front Public Health. 2025 Aug 19;13:1606959. doi: 10.3389/fpubh.2025.1606959. eCollection 2025.
4
() rs738409 Variant and Non-Alcoholic Fatty Liver Disease Risk in Vietnamese Working-Age Adults: A Case-Control Study with Metabolic Insights.
Clin Exp Gastroenterol. 2025 Aug 29;18:191-204. doi: 10.2147/CEG.S532528. eCollection 2025.
5
Metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma: Challenges in clinical practice.
Clin Exp Hepatol. 2025 Jun;11(2):105-112. doi: 10.5114/ceh.2025.151618. Epub 2025 Jun 9.
6
Effects of a two-night hospitalization program as a specific health guidance on obesity and cardiovascular disease risk factors.
J Gen Fam Med. 2025 May 19;26(5):442-450. doi: 10.1002/jgf2.70031. eCollection 2025 Sep.
7
Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease.
World J Hepatol. 2025 Aug 27;17(8):108182. doi: 10.4254/wjh.v17.i8.108182.
8
Myths and facts about the role of diet in metabolic dysfunction-associated steatotic liver disease.
World J Hepatol. 2025 Aug 27;17(8):107909. doi: 10.4254/wjh.v17.i8.107909.
9
Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches.
World J Gastroenterol. 2025 Aug 28;31(32):108827. doi: 10.3748/wjg.v31.i32.108827.
10
Cost-effectiveness of transient elastography for liver fibrosis screening in Thai patients with diabetes mellitus.
World J Gastroenterol. 2025 Aug 28;31(32):110333. doi: 10.3748/wjg.v31.i32.110333.
Zotero 插件